These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 16790543

  • 1. Memantine: the next trend in academic performance enhancement?
    Ota KS, Godwin T.
    J Am Osteopath Assoc; 2006 Jun; 106(6):358-9. PubMed ID: 16790543
    [No Abstract] [Full Text] [Related]

  • 2. [Mechanisms of action of Alzheimer medications].
    Alhainen K.
    Duodecim; 2003 Jun; 119(20):1959-66. PubMed ID: 14640001
    [No Abstract] [Full Text] [Related]

  • 3. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A, Alfaro V.
    Rev Neurol; 2003 Jun; 42(10):607-16. PubMed ID: 16703529
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of memantine in the treatment of Alzheimer's disease].
    Molinuevo Guix JL, Lladó Plarrumaní A.
    Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
    Geerts H, Grossberg GT.
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Memantine (Namenda) for moderate to severe Alzheimer's disease.
    Ables AZ.
    Am Fam Physician; 2004 Mar 15; 69(6):1491-2. PubMed ID: 15053415
    [No Abstract] [Full Text] [Related]

  • 9. [The challenge of Alzheimer dementia].
    Pharm Unserer Zeit; 2003 Mar 15; 32(1):77. PubMed ID: 12577765
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane.
    Zoladz PR, Campbell AM, Park CR, Schaefer D, Danysz W, Diamond DM.
    Pharmacol Biochem Behav; 2006 Oct 15; 85(2):298-306. PubMed ID: 17045636
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS, Rauw G, Baker GB, Kar S.
    Eur J Neurosci; 2008 Nov 15; 28(10):1989-2002. PubMed ID: 19046381
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Memantine facilitates memory consolidation and reconsolidation in the day-old chick.
    Samartgis JR, Schachte L, Hazi A, Crowe SF.
    Neurobiol Learn Mem; 2012 May 15; 97(4):380-5. PubMed ID: 22425751
    [Abstract] [Full Text] [Related]

  • 17. Drugs for Alzheimer's disease.
    Cranwell-Bruce LA.
    Medsurg Nurs; 2010 May 15; 19(1):51-3. PubMed ID: 20336985
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. FDA approves memantine drug for treating AD.
    Am J Alzheimers Dis Other Demen; 2003 May 15; 18(6):329-30. PubMed ID: 14682078
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.